Investigation of pre-eclampsia in pregnant women

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on monitoring pregnant women at high risk for developing pre-eclampsia, a serious condition characterized by high blood pressure and proteinuria. It employs advanced techniques such as NICCOMO and Maternal Venous Doppler Echography, along with bio-electronic impedance analysis, to assess cardiovascular adaptations during pregnancy. The study aims to enhance early detection and treatment through remote monitoring of these patients. A total of 2000 participants will be included from multiple centers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* \> 10 weeks of pregnancy, primipara and multipara

Exclusion Criteria:

* \< 10 weeks of pregnancy and congenital malformations of the fetus

Where it's running

• Ziekenhuis Maas en Kempen
  Bree, Belgium Recruiting
• Ziekenhuis Oost-Limburg
  Genk, Belgium Recruiting
• Jessa Ziekenhuis
  Hasselt, Belgium Recruiting
• Sint-Fransiscus Ziekenhuis
  Heusden-Zolder, Belgium Recruiting
• Heilig Hart Ziekenhuis
  Mol, Belgium Recruiting
• Mariaziekenhuis Oost-Limburg
  Overpelt, Belgium Recruiting

Study contacts

• Principal investigator: Wilfried Gyselaers, prof. dr. — Hasselt University
• Study coordinator: Dorien Lanssens, drs.
• Email: dorien.lanssens@uhasselt.be

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pre-eclampsia risk in pregnancies after oocyte donation

  We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.

  Recruiting at 6 sites Copenhagen University Hospital, Hvidovre · Copenhagen and 5 other locations · NCT07263490

• Use of metformin to prolong pregnancy in preterm preeclampsia in the Netherlands

  In pregnant people with preterm preeclampsia, this study tests whether metformin can help them stay pregnant longer compared with placebo.

  Recruiting Phase 3 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT06452498

• How the placenta affects maternal and fetal health

  This project will test whether tiny particles released by the placenta differ in pregnancies with pre-eclampsia, gestational diabetes, or fetal growth restriction compared with healthy pregnancies and non-pregnant women.

  Recruiting University of Oxford · Oxford · NCT07470320

• Vitamin D to prevent recurrent pre-eclampsia in pregnant women

  This study will test whether taking 4,000 IU of vitamin D during pregnancy lowers the chance of pre-eclampsia returning in women who had it in a prior pregnancy.

  Recruiting Phase 4 Nishtar Medical University · Multan, Punjab Province · NCT07288801

• Investigating cardiovascular risks in women after complicated pregnancies

  This study looks at how having high blood pressure during pregnancy might affect women's heart health later on and whether certain blood tests can help predict their risk for heart problems.

  Recruiting Maastricht University Medical Center · Maastricht · NCT05500989

• Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide

  This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.

  Recruiting Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida · Paris · NCT07921472

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.